chitosan has been researched along with Hemophilia B in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Abriss, D; Königs, C; Milanov, P; Quade-Lyssy, P; Schüttrumpf, J; Seifried, E; Ungerer, C | 1 |
1 other study(ies) available for chitosan and Hemophilia B
Article | Year |
---|---|
Oral gene therapy for hemophilia B using chitosan-formulated FIX mutants.
Topics: Administration, Oral; Animals; Chitosan; Disease Models, Animal; Factor IX; Feasibility Studies; Genetic Therapy; Genotype; HEK293 Cells; Hemophilia B; Hemostasis; Humans; Intestine, Small; Liver; Mice, Inbred C57BL; Mice, Knockout; Mutagenesis, Site-Directed; Mutation; Nanoparticles; Phenotype; Time Factors; Transfection | 2014 |